AI assistant
10x Genomics, Inc. — Director's Dealing 2021
Oct 27, 2021
31830_dirs_2021-10-27_c87ecd6b-05b8-456f-a3f0-a22f9cd91e8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-10-25
Reporting Person: Kosaraju Sridhar (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-25 | Class A Common Stock | S | 100 | $163.85 | Disposed | 7400 | Indirect |
| 2021-10-25 | Class A Common Stock | S | 600 | $165.1407 | Disposed | 6800 | Indirect |
| 2021-10-25 | Class A Common Stock | S | 400 | $166.6033 | Disposed | 6400 | Indirect |
| 2021-10-25 | Class A Common Stock | S | 100 | $167.63 | Disposed | 6300 | Indirect |
| 2021-10-25 | Class A Common Stock | S | 300 | $168.6800 | Disposed | 6000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 3458 | Direct |
Footnotes
F1: The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
F2: These shares are held by the Kosaraju Family Trust.
F3: This transaction was executed in multiple trades at prices ranging from $164.57 to $165.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $166.23 to $167.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $168.49 to $168.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.